GoodmanL., and GilmanA., The Pharmacological Basis of Therapeutics, 4th ed., pp. 123–125, The MacMillan Co., N.Y.1970.
5.
BerstineJ.B.: Maternal Blood and Cerebrospinal Fluid Estimation Following the Administration of Chloral Hydrate During the Puerperium, Amer. J. Obstet. Gynecol.73: 801–804 (Apr.) 1957.
6.
FriedmanP. J., and CooperJ. R.: The Role of Alcohol Dehydrogenase in the Metabolism of Chloral Hydrate, J. Pharmacol. Exp. Ther.129: 373–376, 1960.
7.
MarshallE. K., and OwensA. H.: Absorption, Excretion and Metabolic Fate of Chloral Hydrate and Trichlorethanol, Bull. Johns Hopkins Hasp.95: 1–18 (Jan.) 1954.
8.
CormanL.A.: Double-Blind Comparison of the Hypnotic Effect of Trichlorethyl Phosphate, Phenobarbital and Placebo, Curr. Ther. Res.10: 1–5 (Jan.) 1968.
9.
HenschelE.O.: Evaluation of Monosodium Trichlorethyl Phosphate (Triclofos) as a Preoperative Sedative Compared to Chloral Hydrate and a Placebo, Curr. Ther. Res.9: 453–456 (Sept.) 1967.
10.
MattsG. F., and WhartonB. A.: An Assessment of the Value of Trichlorethyl Phosphate in Night Sedation, Brit. J. Clin. Prac.17: 511–513 (Sept.) 1963.
11.
KalesA.: Drugs and Dreaming, Prog. Clin. Psychology, Grune and Stratton Inc., N.Y., pp 154–166, 1969.
12.
CucinellS.A.: The Effect of Chloral Hydrate on Bishydroxycoumarin Metabolism, J. Amer. Med. Ass.197: 366–368 (Aug. 1) 1966.
13.
SellersE. M., and Koch-WesserJ.: Potentiation of Warfarin-Induced Hypoprothrombinemia by Chloral Hydrate, N. E. J. Med.283: 827–831 (Oct. 15) 1970.
14.
GrinerP.F.: Chloral Hydrate and Warfarin Interaction: Clinical Significance?, Ann. Intern. Med.74: 540 (Apr.) 1971.
15.
HanstenP. D.: Drug Interactions, page 34, Lea and Febiger, Philadelphia, 1971.
16.
Boston Collaborative Drug Surveillance Program: Interaction Between Chloral Hydrate and Warfarin, N. E. J. Med.286: 53–55 (Jan. 13) 1972.
17.
SellersE.M.: Enhancement of Warfarin-Induced Hypoprothrombinemia by Triclofos, Clin. Pharmacol. Ther.13: 911–915 (Nov.-Dec.) 1972.